Evaluating Volatile Organic Compound Emissions from Cross-Laminated Timber Bonded with a Soy-Based Adhesive

Volatile organic compound (VOC) emissions from indoor sources are large determinants of the indoor air quality (IAQ) and occupant health. Cross-laminated timber (CLT) is a panelized engineered wood product often left exposed as an interior surface finish. As a certified structural building product, CLT is currently exempt from meeting VOC emission limits for composite wood products and confirming emissions through California Department of Public Health (CDPH) Standard Method testing. In this study, small chamber testing was conducted to evaluate VOC emissions from three laboratory-produced CLT samples: One bonded with a new soy-based cold-set adhesive; a second bonded with a commercially available polyurethane (PUR) adhesive; and the third assembled without adhesive using dowels. A fourth commercially-produced eight-month-old sample bonded with melamine formaldehyde (MF) adhesive was also tested. All four samples were produced with Douglas-fir. The test results for the three laboratory-produced samples demonstrated VOC emissions compliance with the reference standard. The commercially-produced and aged CLT sample bonded with MF adhesive did not meet the acceptance criterion for formaldehyde of ≤9.0 µg/m3. The estimated indoor air concentration of formaldehyde in an office with the MF sample was 54.4 µg/m3; the results for the soy, PUR, and dowel samples were all at or below 2.5 µg/m3

Clinical trials in neonates: ethical issues

Clinical trials in neonatology often raise complex ethical problems. This paper suggests that in tackling these it is useful to identify and separate out those elements of the problem that are genuinely ethical (e.g. can I enter a child into a trial if I am not in personal equipoise?) from those that are empirical (e.g. what is the evidence for a treatment's effectiveness?) and those that are formal (e.g. what do codes or the law permit?) The genuinely ethical elements are examples of philosophical problems and must be tackled in a way appropriate to such problems. In practice this usually means some form of systematic argument. This is often frustrating to clinicians who are more used to the assuredness of empirical research. The paper next examines two ethical problems that arise frequently in neonatal trials. The first is equipoise and the related issue of recruiting parents who are not in equipoise because they strongly desire that their baby get the active treatment. We briefly defend the recruitment of such "desperate volunteers". The second is informed consent. We discuss the nature and value of informed consent and suggest that clinicians can often obtain worthwhile consent even in very difficult trials. The final section of the paper uses the example of clinical trials for brain injury to illustrate the difficulties.</p

An Application Of A Hydrostatic Pressure Lift System For Control Of Variable Thrust Loads.

LecturePg. 27-32Thrust bearing failures on older equipment, especially large steam turbines, can be costly problems to remedy. A unique solution to a steam turbine thrust bearing problem that confronted Southern California Edison (SCE) is examined. The prohibitive cost of correcting the problem had forced SCE to consider mothballing the turbine. An evaluation of the situation by experts in the area of thrust bearing design produced a cost effective solution-a hydrostatic assisted thrust bearing design. The solution was implemented, and the results have proven satisfactory

A Provenance Methodology And Architecture For Scientific Projects Containing Automated And Manual Processes

The management of provenance metadata is a pressing issue for high profile, complex, science projects needing to trace their data products’ lineage in order to withstand scrutiny. To represent, capture, transfer, store and deliver provenance data from a project’s processes, specialized metadata, new IT system components and the human and automated procedures are necessary. The collection of metadata, components and procedures can be termed a provenance methodolo-gy and architecture. Through our involvement with several large Australian science projects ([4], [5], [6], [7], [11]), we have developed a methodology that provides: Use Case assessments of project clients’ requirements for provenance; team structures and project processes to facilitate provenance requirements; systems’ behaviour to capture provenance from automated processes; behavioural patterns for project staff to capture provenance from manual processes; procedures for process compiling, storing and using provenance records. Semantic web provenance ontologies have been created ([1], [2], [3]) that allow generic, ab-stracted provenance representation and we have extended the PROV ontology through our prov-enance data management ontology (PROMS-O) [8] in order to address provenance Use Cases required by our projects that PROV-O does not address. Due to our project experience, we have developed a provenance architecture that specifies: a single provenance representation format for all project processes; the use of a persistent ID systems to alias other systems’ URIs; an archival systems to store data and provide access to versions of their data via URIs; provenance management systems to store and provide access to provenance data; provenance exporters to capture and transmit provenance data from automated systems; provenance procedures to collect provenance data from human processes, and; an overarching integration architecture. In this paper, we briefly mention our work regarding each of the points above which, together, provide a range of pointers to projects wanting to embark on provenance management

Seasonal variability of the warm Atlantic Water layer in the vicinity of the Greenland shelf break

The warmest water reaching the east and west coast of Greenland is found between 200?m and 600?m. Whilst important for melting Greenland's outlet glaciers, limited winter observations of this layer prohibit determination of its seasonality. To address this, temperature data from Argo profiling floats, a range of sources within the World Ocean Database and unprecedented coverage from marine-mammal borne sensors have been analysed for the period 2002-2011. A significant seasonal range in temperature (~1-2?°C) is found in the warm layer, in contrast to most of the surrounding ocean. The phase of the seasonal cycle exhibits considerable spatial variability, with the warmest water found near the eastern and southwestern shelf-break towards the end of the calendar year. High-resolution ocean model trajectory analysis suggest the timing of the arrival of the year's warmest water is a function of advection time from the subduction site in the Irminger Basin

Evaluating Volatile Organic Compound Emissions from Cross-Laminated Timber Bonded with a Soy-Based Adhesive

11 pagesVolatile organic compound (VOC) emissions from indoor sources are large determinants of the indoor air quality (IAQ) and occupant health. Cross-laminated timber (CLT) is a panelized engineered wood product often left exposed as an interior surface finish. As a certified structural building product, CLT is currently exempt from meeting VOC emission limits for composite wood products and confirming emissions through California Department of Public Health (CDPH) Standard Method testing. In this study, small chamber testing was conducted to evaluate VOC emissions from three laboratory-produced CLT samples: One bonded with a new soy-based cold-set adhesive; a second bonded with a commercially available polyurethane (PUR) adhesive; and the third assembled without adhesive using dowels. A fourth commercially-produced eight-month-old sample bonded with melamine formaldehyde (MF) adhesive was also tested. All four samples were produced with Douglas-fir. The test results for the three laboratory-produced samples demonstrated VOC emissions compliance with the reference standard. The commercially-produced and aged CLT sample bonded with MF adhesive did not meet the acceptance criterion for formaldehyde of ≤9.0 μg/m3. The estimated indoor air concentration of formaldehyde in an office with the MF sample was 54.4 μg/m3; the results for the soy, PUR, and dowel samples were all at or below 2.5 μg/m3.This research was funded by the U.S. Department of Agriculture’s Agricultural Research Service [USDA ARS Agreement 58-0204-6-002]

Assessing the pathogenicity of insertion and deletion variants with the Variant Effect Scoring Tool (VEST-Indel)

Insertion/deletion variants (indels) alter protein sequence and length, yet are highly prevalent in healthy populations, presenting a challenge to bioinformatics classifiers. Commonly used features—DNA and protein sequence conservation, indel length, and occurrence in repeat regions—are useful for inference of protein damage. However, these features can cause false positives when predicting the impact of indels on disease. Existing methods for indel classification suffer from low specificities, severely limiting clinical utility. Here, we further develop our variant effect scoring tool (VEST) to include the classification of in-frame and frameshift indels (VEST-indel) as pathogenic or benign. We apply 24 features, including a new “PubMed” feature, to estimate a gene's importance in human disease. When compared with four existing indel classifiers, our method achieves a drastically reduced false-positive rate, improving specificity by as much as 90%. This approach of estimating gene importance might be generally applicable to missense and other bioinformatics pathogenicity predictors, which often fail to achieve high specificity. Finally, we tested all possible meta-predictors that can be obtained from combining the four different indel classifiers using Boolean conjunctions and disjunctions, and derived a meta-predictor with improved performance over any individual method

Coevolution of insulin-like growth factors, insulin and their receptors and binding proteins in new world monkeys

Previous work has shown that the evolution of both insulin-like growth factor 1 (IGF1) and insulin shows an episode of accelerated change on the branch leading to New World monkeys (NWM). Here the possibility that this is accompanied by a corresponding episode of accelerated evolution of IGF1 receptor (IGF1R), insulin receptor (IR) and/or IGF binding proteins (IGFBPs) was investigated. Analysis of receptor sequences from a range of primates and some non-primate mammals showed that accelerated evolution did indeed occur on this branch in the case of IGF1R and IR, but not for the similar insulin receptor-related receptor (IRRR) which does not bind insulin or IGF1. Marked accelerated evolution on this branch was also seen for some IGFBPs, but not the mannose 6-phosphate/IGF2 receptor or epidermal growth factor receptor. The rate of evolution slowed before divergence of the lineages leading to the NWM for which sequences are available (Callithrix and Saimiri). For the IGF1R and IR the accelerated evolution was most marked for the extracellular domains (ectodomains). Application of the branch-sites method showed dN/dS ratios significantly greater than 1.0 for both receptor ectodomains and for IGFBP1, and allowed identification of residues likely to have been subject to selection. These residues were concentrated in the N-terminal half of the IGF1R ectodomain but the C-terminal half of the IR ectodomain, which could have implications for the formation of hybrid receptors. Overall the results suggest that adaptive coevolution of IGF1, insulin and their receptors and some IGFBPs occurred during the evolution of NWM. For the most part, the residues that change on this branch could not be associated with specific functional aspects (ligand binding, receptor dimerization, glycosylation) and the physiological significance of this coevolution remains to be established

Genomic variation in myeloma: design, content, and initial application of the Bank On A Cure SNP Panel to detect associations with progression-free survival

<p>Abstract</p> <p>Background</p> <p>We have engaged in an international program designated the <it>Bank On A Cure</it>, which has established DNA banks from multiple cooperative and institutional clinical trials, and a platform for examining the association of genetic variations with disease risk and outcomes in multiple myeloma.</p> <p>We describe the development and content of a novel custom SNP panel that contains 3404 SNPs in 983 genes, representing cellular functions and pathways that may influence disease severity at diagnosis, toxicity, progression or other treatment outcomes. A systematic search of national databases was used to identify non-synonymous coding SNPs and SNPs within transcriptional regulatory regions. To explore SNP associations with PFS we compared SNP profiles of short term (less than 1 year, <it>n </it>= 70) versus long term progression-free survivors (greater than 3 years, <it>n </it>= 73) in two phase III clinical trials.</p> <p>Results</p> <p>Quality controls were established, demonstrating an accurate and robust screening panel for genetic variations, and some initial racial comparisons of allelic variation were done. A variety of analytical approaches, including machine learning tools for data mining and recursive partitioning analyses, demonstrated predictive value of the SNP panel in survival. While the entire SNP panel showed genotype predictive association with PFS, some SNP subsets were identified within drug response, cellular signaling and cell cycle genes.</p> <p>Conclusion</p> <p>A targeted gene approach was undertaken to develop an SNP panel that can test for associations with clinical outcomes in myeloma. The initial analysis provided some predictive power, demonstrating that genetic variations in the myeloma patient population may influence PFS.</p

MRI-derived g-ratio and lesion severity in newly diagnosed multiple sclerosis

Myelin loss is associated with axonal damage in established multiple sclerosis. This relationship is challenging to study in vivo in early disease. Here, we ask whether myelin loss is associated with axonal damage at diagnosis, by combining non-invasive neuroimaging and blood biomarkers. We performed quantitative microstructural MRI and single molecule ELISA plasma neurofilament measurement in 73 patients with newly diagnosed, immunotherapy naïve relapsing-remitting multiple sclerosis. Myelin integrity was evaluated using aggregate g-ratios, derived from magnetization transfer saturation (MTsat) and neurite orientation dispersion and density imaging (NODDI) diffusion data. We found significantly higher g-ratios within cerebral white matter lesions (suggesting myelin loss) compared with normal-appearing white matter (0.61 vs 0.57, difference 0.036, 95% CI 0.029 to 0.043, p &amp;lt; 0.001). Lesion volume (Spearman’s rho rs= 0.38, p &amp;lt; 0.001) and g-ratio (rs= 0.24 p &amp;lt; 0.05) correlated independently with plasma neurofilament. In patients with substantial lesion load (n = 38), those with higher g-ratio (defined as greater than median) were more likely to have abnormally elevated plasma neurofilament than those with normal g-ratio (defined as less than median) (11/23 [48%] versus 2/15 [13%] p &amp;lt; 0.05). These data suggest that, even at multiple sclerosis diagnosis, reduced myelin integrity is associated with axonal damage. MRI-derived g-ratio may provide useful additional information regarding lesion severity, and help to identify individuals with a high degree of axonal damage at disease onset. York, Martin et al. simultaneously measured g-ratio and plasma neurofilament in 73 relapsing-remitting multiple sclerosis patients at diagnosis using advanced MRI and single molecule ELISA. They demonstrate that g-ratio of cerebral white matter lesions varies at diagnosis, and show that high g-ratio of lesions is associated with elevated plasma neurofilament